Clinical Trial Update: Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluated tacrolimus in combination with low-dose corticosteroid for adults with Minimal Change Disease and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Minimal Change Disease

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Minimal Change Disease | Phase 2, Phase 3 | Status: COMPLETED